Dr Ross Walker shares his criticisms about how the coronavirus pandemic has been handled.

Peter Switzer and Paul Rickard discuss masking up for the economy, rising gold prices and the looming reporting season.

On this week's show: Burman Invest's Julia Lee, Medallion's Michael Wayne, Morgans' Michael Knox and Switzer's Paul Rickard.

Dr Ross Walker examines the effectiveness of hydroxychloroquine.

Peter Switzer and Paul Rickard discuss gains in the stock market despite infection rates in Victoria and the US, the Aussie dollar moving above 71 US cents and when employees will head back to the office.

Joining Peter Switzer on this week's show: Burman Invest's Julia Lee, Shaw and Partners' Adam Dawes, FNArena's Rudi Filapek-Vandyck and Metrics Credit Partners' Andrew Lockhart.

With over 100 vaccines for COVID-19 currently being trialled, Dr Ross Walker explains what vaccination is and how the latest research into Coronavirus vaccines is progressing.

Peter Switzer is joined by the Managing Director of Rafaella Resources (RFR), Steven Turner.

Peter Switzer and Paul Rickard discuss problems with the compulsory superannuation system, Wall Street madness overnight, the COVID-19 situation in Victoria and what the iron ore price says about the economy.

Julia Lee, James Graham, Rhys Cohen and Paul Rickard join this week's show to discuss investing in the drug space.

Dr Ross Walker explains what kind of people and places are more susceptible to the Coronavirus.

Peter Switzer and Paul Rickard discuss the latest news on Afterpay, Victorian Premier Daniel Andrew's handling of COVID-19 and why US share players are ignoring a spike in cases.